| Previous Close | 1.6800 |
| Open | 1.6900 |
| Bid | 1.6400 x 2200 |
| Ask | 1.6500 x 4000 |
| Day's Range | 1.6200 - 1.6900 |
| 52 Week Range | 0.7500 - 2.4000 |
| Volume | 1,474,004 |
| Avg. Volume | 4,005,715 |
| Market Cap | 509.002M |
| Beta (5Y Monthly) | 1.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3660 |
| Earnings Date | Aug. 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.50 |
- Business Wire
Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call today at 4:30 p.m. ET to discuss second quarter financial results and current events.
- Business Wire
Geron to Present at the BTIG Virtual Biotechnology Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August 11, 2020 at 12:30 p.m. ET.
- Business Wire
Geron to Announce Second Quarter Financial Results on August 6, 2020
Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as recent events at 4:30 p.m. ET the same day.
